212
Participants
Start Date
April 8, 2025
Primary Completion Date
April 8, 2028
Study Completion Date
July 1, 2028
Apixaban
5 mg tablet twice a daily with dose reduction according to label
Warfarin
2.5 mg tablet once daily, with individual dosing according to coagulation tests
RECRUITING
Karolinska Insitutet, Stockholm
NOT_YET_RECRUITING
Falu lasarett, Falun
NOT_YET_RECRUITING
Sahlgrenska University hospital, Mölndal, Gothenburg
NOT_YET_RECRUITING
Sahlgrenska University hospital, Östra, Gothenburg
NOT_YET_RECRUITING
Sahlgrenska University hospital, Gothenburg
NOT_YET_RECRUITING
Linköping University hospital, Linköping
RECRUITING
Skånes Universitetssjukhus Lund, Lund
NOT_YET_RECRUITING
Skånes University hospital, Malmö, Malmo
NOT_YET_RECRUITING
Vrinnevi hospital, Nörrköping
NOT_YET_RECRUITING
Örebro University hospital, Örebro
NOT_YET_RECRUITING
Danderyds hospital, Stockholm
RECRUITING
Karolinska Univerity Hospital, Stockholm
NOT_YET_RECRUITING
Sankt Görans Hospital, Stockholm
NOT_YET_RECRUITING
Södersjukhuset, Stockholm
NOT_YET_RECRUITING
Uppsala Akademiska hospital, Uppsala
NOT_YET_RECRUITING
Västmanlands hospital, Västerås, Västerås
Karolinska Trial Alliance
INDUSTRY
Swedish Heart Lung Foundation
OTHER
The Swedish Research Council
OTHER_GOV
Stockholm County Council ALF/PPG
UNKNOWN
Karolinska Institutet
OTHER